S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
The 3-Stock Retirement Blueprint (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
The 3-Stock Retirement Blueprint (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
The 3-Stock Retirement Blueprint (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
The 3-Stock Retirement Blueprint (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
The 3-Stock Retirement Blueprint (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
The 3-Stock Retirement Blueprint (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
The 3-Stock Retirement Blueprint (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
The 3-Stock Retirement Blueprint (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
The 3-Stock Retirement Blueprint (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
The 3-Stock Retirement Blueprint (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
The 3-Stock Retirement Blueprint (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
The 3-Stock Retirement Blueprint (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
NYSEAMERICAN:ATNM

Actinium Pharmaceuticals - ATNM Institutional Ownership

$7.94
+0.05 (+0.63%)
(As of 10/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$7.57
$8.03
50-Day Range
N/A
52-Week Range
$4.41
$9.21
Volume
144,327 shs
Average Volume
376,907 shs
Market Capitalization
$199.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$26.50

Institutional Ownership Changes (13F Filings) for Actinium Pharmaceuticals (NYSEAMERICAN:ATNM)

Current
Institutional Ownership
Percentage
8.63%
Number of
Institutional Buyers
(last 12 months)
17
Total
Institutional Inflows
(last 12 months)
$2.14 M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$312,444.44
Skip Chart & View Institutional Buying and Selling Data

ATNM Institutional Buying and Selling by Quarter

Get ATNM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Actinium Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Actinium Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/16/2022Corton Capital Inc.16,285$78K0.1%N/A0.068%
8/16/2022Delphia USA Inc.17,669$85K0.1%N/A0.074%
8/15/2022State Street Corp75,215$0.36M0.0%+19.4%0.316%
8/15/2022Cubist Systematic Strategies LLC31,484$0.15M0.0%N/A0.132%
8/15/2022Millennium Management LLC33,140$0.16M0.0%N/A0.139%
8/13/2022Virtu Financial LLC35,789$0.17M0.0%+154.0%0.150%
8/13/2022Renaissance Technologies LLC57,700$0.28M0.0%N/A0.243%
6/7/2022Bank of America Corp DE19,778$0.10M0.0%-17.3%0.083%
5/16/2022State Street Corp63,015$0.32M0.0%+12.5%0.285%
5/13/2022Vanguard Group Inc.858,837$4.39M0.0%-0.8%3.878%
5/13/2022Blair William & Co. IL100,566$0.51M0.0%+15.8%0.454%
5/12/2022BlackRock Inc.230,950$1.18M0.0%+1.1%1.043%
5/11/2022ACT Capital Management LLC6,500$33K0.0%-82.7%0.029%
2/14/2022Blair William & Co. IL86,866$0.52M0.0%+5.5%0.394%
2/14/2022GSA Capital Partners LLP56,673$0.34M0.0%-16.9%0.257%
11/16/2021ACT Capital L.L.C.37,500$0.33M0.2%N/A0.170%
11/15/2021Marshall Wace LLP22,469$0.20M0.0%N/A0.102%
11/15/2021Wealthspire Advisors LLC14,348$0.13M0.0%N/A0.065%
11/15/2021GSA Capital Partners LLP68,205$0.60M0.1%+44.8%0.310%
11/15/2021Interchange Capital Partners LLC16,420$0.15M0.2%+43.8%0.075%
11/12/2021Rockefeller Capital Management L.P.8,381$74K0.0%+21.8%0.038%
11/12/2021Geode Capital Management LLC167,172$1.48M0.0%+9.5%0.759%
11/12/2021Bank Julius Baer & Co. Ltd Zurich8,833$78K0.0%+132.9%0.040%
11/9/2021BlackRock Inc.219,243$1.94M0.0%-1.5%0.995%
8/17/2021Bridgeway Capital Management LLC99,166$0.78M0.0%+17.5%0.465%
8/16/2021First Trust Advisors LP51,273$0.41M0.0%+43.5%0.240%
8/16/2021Morgan Stanley21,489$0.17M0.0%+368.3%0.101%
8/16/2021State Street Corp55,292$0.44M0.0%N/A0.259%
8/13/2021Northern Trust Corp38,052$0.30M0.0%+40.4%0.178%
8/13/2021Geode Capital Management LLC152,678$1.21M0.0%+53.0%0.716%
8/13/2021Vanguard Group Inc.819,642$6.48M0.0%+43.2%3.842%
8/12/2021Blair William & Co. IL51,466$0.41M0.0%+48.0%0.241%
8/5/2021GSA Capital Partners LLP47,097$0.37M0.0%+20.7%0.221%
8/2/2021Pinnacle Associates Ltd.34,333$0.27M0.0%N/A0.170%
7/31/2021Goodwin Daniel L10,000$80K0.0%-50.0%0.050%
5/18/2021Silverarc Capital Management LLC45,910$0.35M0.2%-49.0%0.239%
5/13/2021Bank of New York Mellon Corp50,793$0.39M0.0%-8.8%0.264%
5/13/2021Blair William & Co. IL34,766$0.27M0.0%N/A0.181%
5/11/2021Rockefeller Capital Management L.P.6,881$52K0.0%+82.0%0.036%
5/10/2021GSA Capital Partners LLP39,006$0.30M0.0%N/A0.203%
2/24/2021Virtu Financial LLC27,524$0.22M0.0%N/A0.203%
2/16/2021Silverarc Capital Management LLC90,000$0.70M0.4%N/A0.662%
2/16/2021ExodusPoint Capital Management LP11,900$93K0.0%N/A0.088%
2/9/2021Wells Fargo & Company MN17,380$0.14M0.0%+2,954.5%0.128%
2/9/2021Bank of New York Mellon Corp55,665$0.43M0.0%+30.9%0.410%
2/5/2021BlackRock Inc.199,654$1.56M0.0%+0.7%1.469%
2/2/2021DCM Advisors LLC13,300$0.10M0.1%N/A0.098%
2/2/2021First Trust Advisors LP32,872$0.26M0.0%-4.3%0.242%
11/16/2020J. Goldman & Co LP168,749$1.64M0.1%-92.2%1.242%
11/16/2020Consonance Capital Management LP793,170$7.69M0.9%-97.9%5.838%
11/13/2020Morgan Stanley33,747$0.33M0.0%+3.3%0.248%
11/12/2020Arrowstreet Capital Limited Partnership28,500$0.28M0.0%-81.2%0.210%
11/10/2020Bank Julius Baer & Co. Ltd Zurich5,131$50K0.0%-98.5%0.038%
11/6/2020BlackRock Inc.198,320$1.92M0.0%-97.8%1.460%
11/6/2020GSA Capital Partners LLP13,823$0.13M0.0%N/A0.102%
11/5/2020First Trust Advisors LP34,353$0.33M0.0%N/A0.253%
8/31/2020Bridgeway Capital Management Inc.275,000$97K0.0%N/A2.024%
8/14/2020Sabby Management LLC972,285$0.34M0.1%+56.4%7.164%
8/14/2020Advisor Group Holdings Inc.70,033$25K0.0%+7.7%0.516%
8/13/2020Laidlaw Wealth Management LLC19,684$56K0.2%N/A0.145%
8/13/2020ETRADE Capital Management LLC80,200$28K0.0%N/A0.591%
8/7/2020Virtu Financial LLC668,600$0.24M0.0%N/A0.169%
8/5/2020Russell Investments Group Ltd.742,700$0.26M0.0%N/A0.188%
8/5/2020Oxford Financial Group Ltd.107,200$38K0.0%N/A0.027%
7/31/2020UBS Group AG73,109$26K0.0%-44.1%0.019%
5/15/2020Sabby Management LLC621,840$0.12M0.1%-81.0%0.205%
5/8/2020PNC Financial Services Group Inc.198,480$38K0.0%-80.8%0.052%
5/1/2020BlackRock Inc.2,007,529$0.39M0.0%+70.2%1.147%
2/14/2020UBS Group AG174,990$38K0.0%+119.7%0.107%
2/13/2020Renaissance Technologies LLC990,343$0.22M0.0%+97.8%0.603%
2/4/2020Virtu Financial LLC407,794$89K0.0%+295.0%0.248%
11/27/2019Sabby Management LLC8,797,509$2.02M1.1%+5.4%5.342%
11/27/2019Endurant Capital Management LP1,354,172$0.31M0.1%-45.4%0.825%
8/14/2019Sio Capital Management LLC4,935,250$1.21M0.3%+1,352.4%3.046%
8/14/2019Vanguard Group Inc.3,026,265$0.75M0.0%-33.6%1.868%
8/10/2019Oppenheimer & Co. Inc.236,281$58K0.0%+34.6%0.146%
4/24/2019Oppenheimer & Co. Inc.175,512$84K0.0%+69.3%0.147%
2/8/2019PNC Financial Services Group Inc.1,031,210$0.40M0.0%+23.8%0.891%
1/16/2019Virtu Financial LLC84,128$33K0.0%-57.0%0.073%
12/13/2018Vanguard Group Inc2,575,754$1.91M0.0%+6.4%2.226%
11/23/2018Vanguard Group Inc.2,575,754$1.91M0.0%+6.4%2.226%
11/13/2018DLD Asset Management LP1,313,431$0.97M0.0%-60.2%1.145%
11/13/2018Virtu Financial LLC195,623$0.15M0.0%+103.1%0.171%
11/9/2018PNC Financial Services Group Inc.832,730$0.62M0.0%N/A0.726%
10/16/2018Essex Investment Management Co. LLC1,101,086$0.82M0.1%N/A0.997%
8/15/2018Sio Capital Management LLC872,406$0.56M0.3%-18.9%0.790%
8/13/2018Renaissance Technologies LLC387,500$0.25M0.0%+1,269.5%0.352%
8/9/2018BlackRock Inc.469,578$0.30M0.0%-27.6%0.426%
5/25/2018Worth Venture Partners LLC381,431$0.14M0.1%N/A0.346%
5/16/2018Sio Capital Management LLC1,076,200$0.39M0.2%N/A0.977%
5/15/2018Anson Funds Management LP4,113,892$1.50M1.1%N/A3.733%
5/15/2018Sabby Management LLC1,997,700$0.73M0.1%N/A1.813%
5/11/2018Worth Venture Partners LLC381,431$0.14M0.1%N/A0.346%
2/8/2018D.A. Davidson & CO.157,000$0.10M0.0%+227.1%0.196%
(Data available from 1/1/2016 forward)













ATNM Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ATNM shares?

During the previous two years, 34 institutional investors and hedge funds held shares of Actinium Pharmaceuticals. The most heavily invested institutionals were Consonance Capital Management LP ($7.69M), Vanguard Group Inc. ($4.39M), J. Goldman & Co LP ($1.64M), Geode Capital Management LLC ($1.48M), BlackRock Inc. ($1.18M), Bridgeway Capital Management LLC ($0.78M), and Blair William & Co. IL ($0.51M).Learn more on ATNM's institutional investors.

What percentage of Actinium Pharmaceuticals stock is owned by institutional investors?

8.63% of Actinium Pharmaceuticals stock is owned by institutional investors. Learn more on ATNM's institutional investor holdings.

Which institutional investors have been buying Actinium Pharmaceuticals stock?

Of the 28 institutional investors that purchased Actinium Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vanguard Group Inc. ($0.25M), Silverarc Capital Management LLC ($90K), GSA Capital Partners LLP ($82.03K), State Street Corp ($74.52K), Blair William & Co. IL ($69.67K), Geode Capital Management LLC ($67.37K), and Renaissance Technologies LLC ($57.70K).

How much institutional buying is happening at Actinium Pharmaceuticals?

Institutional investors have bought a total of 1,112,142 shares in the last 24 months. This purchase volume represents approximately $10.13M in transactions.

Which Actinium Pharmaceuticals major shareholders have been selling company stock?

Of the 13 institutional investors that sold Actinium Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Consonance Capital Management LP ($36.21M), BlackRock Inc. ($8.83M), J. Goldman & Co LP ($1.98M), Bank Julius Baer & Co. Ltd Zurich ($0.34M), Arrowstreet Capital Limited Partnership ($0.12M), Silverarc Capital Management LLC ($44.09K), and ACT Capital Management LLC ($31K).

How much institutional selling is happening at Actinium Pharmaceuticals?

Institutional investors have sold a total of 47,590,858 shares in the last 24 months. This volume of shares sold represents approximately $920.83M in transactions.

This page (NYSEAMERICAN:ATNM) was last updated on 10/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.